Clicky

Monday, November 2, 2026

Earnings

Results and financial condition

Celularity Inc files amended annual report for 2025 results

Celularity Inc has filed an amended annual report for 2025, impacting financial transparency in the pharmaceutical preparations sector.

MSC Industrial Direct files annual 10-K report detailing results

MSC Industrial Direct Co Inc. files its 10-K report, revealing key financial insights and operational updates for the wholesale-industrial machinery sector.

FactSet Research Systems Inc. releases annual report for 2026

FactSet Research Systems Inc. has released its annual report, detailing financial performance and strategic direction for the year ending August 31, 2026.

Crown Holdings reports third-quarter earnings for 2026

Crown Holdings, Inc. announces its third-quarter earnings for 2026, reflecting financial performance and industry trends in the metal can sector.

Panamera Holdings Corp Issues Non-Reliance Statement on Finances

Panamera Holdings Corp announces non-reliance on past financial statements due to undisclosed obligations, impacting the management consulting sector.

Commercial Bancgroup reports Q3 earnings, declares dividend

Commercial Bancgroup, Inc. announces strong Q3 earnings of $10.9 million and a quarterly cash dividend of $0.12 per share.

Blue Ridge Bankshares reports third-quarter results

Blue Ridge Bankshares, Inc. announces its third-quarter financial results, impacting the state commercial banks sector and stakeholders.

Brown & Brown Reports Third-Quarter Results for 2026

Brown & Brown, Inc. announces its third-quarter results for 2026, highlighting strong performance in the insurance sector.

Noble Corp plc announces Q3 2026 financial results

Noble Corp plc reports its Q3 2026 financial results, impacting the drilling oil and gas wells industry and setting the stage for future performance discussions.

Jazz Pharmaceuticals Reports $755 Million Charge from Acquisition

Jazz Pharmaceuticals announces a $755 million pre-tax charge due to its acquisition of Actio Biosciences, impacting Q3 earnings significantly.

Avidbank Holdings reports strong Q3 2026 financial results

Avidbank Holdings, Inc. announces a significant increase in net income for Q3 2026, reflecting growth in loans and deposits.

Cadence Design Systems Raises Q3 2026 Revenue Outlook, Announces Buyback

Cadence Design Systems reports strong Q3 2026 results and raises revenue outlook to 21%. The company also announces a $2.5 billion share repurchase program.

Crown Castle reports Q3 results, adjusts 2026 outlook

Crown Castle Inc. announces third-quarter financial results and updates its outlook for 2026, indicating challenges in site rental revenues.

Silvercrest to Host Teleconference for Q3 Financial Results

Silvercrest Asset Management Group Inc. announces a teleconference to discuss Q3 financial results on October 30, 2026, emphasizing transparency and stakeholder engagement.

First Eagle Private Credit Fund Reports Unregistered Share Sales

First Eagle Private Credit Fund announces unregistered sales of Class I common shares, a strategic move to enhance its capital structure.

FVCBankcorp reports Q3 2026 earnings, declares dividend

FVCBankcorp, Inc. announces a 19% increase in net income for Q3 2026 and declares a cash dividend of $0.07 per share.

Ponce Financial Group reports Q3 2026 financial results

Ponce Financial Group, Inc. announces its financial results for Q3 2026, impacting investor sentiment and competition in the savings institution sector.

Amneal Pharmaceuticals amends report on Kashiv acquisition

Amneal Pharmaceuticals has filed an amended report detailing its acquisition of Kashiv BioSciences, enhancing its financial position.

Essential Properties Realty Trust Reports Q3 2026 Results

Essential Properties Realty Trust, Inc. announces financial results for Q3 2026, reporting a net income per share of $0.27 and increased AFFO guidance.

Acumen Pharmaceuticals reports Q3 2026 results, updates on trials

Acumen Pharmaceuticals shares Q3 2026 financial results, updates on Alzheimer's trials, and cash position, indicating strong future growth potential.

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →